Table 1 CR1 genotypes and allele frequencies in patients with chronic CD and healthy controls.

From: Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease

CR1 genetic variants

Control n = 102 (%)

CD Patients n = 220 (%)

Indeter minate n = 87 (%)

Cardiac n = 77 (%)

Digestive n = 19 (%)

Cardio digestive n = 31 (%)

CD Patients vs. Controls p value; OR [95% CI]

Indeterminate vs. Controls p value; OR [95% CI]

Cardiac vs. Controls p value; OR [95% CI]

Digestive vs. Controls p value; OR [95% CI]

rs17259045A/G

AA

82 (80)

190 (87)

75 (86)

69 (90)

16 (84)

25 (81)

    

AG

20 (20)

27 (12)

11 (13)

7 (9)

3 (16)

5 (16)

NS

NS

NS

NS

GG

0

3 (1)

1 (1)

1 (1)

0

1 (3)

A*

184 (90)

407 (92)

161 (92)

145 (94)

35 (92)

55 (89)

NS

NS

NS

NS

G

20 (10)

33 (8)

13 (8)

9 (6)

3 (8)

7 (11)

rs41274768G/A

GG

98 (96)

198 (90)

80 (92)

70 (91)

16 (84)

27 (87)

    

GA

4 (4)

22 (10)

7 (8)

7 (9)

3 (16)

4 (13)

NS

NS

NS

NS

AA

0

0

0

0

0

0

G*

200 (98)

418 (95)

167 (96)

147 (95)

35 (92)

58 (93)

NS

NS

NS

NS

A

4 (2)

22 (5)

7 (4)

7 (5)

3 (8)

4 (7)

rs17047660A/G

AA

100 (98)

202 (92)

81 (93)

70 (91)

19 (100)

28 (90)

    

AG

2 (2)

15 (7)

5 (6)

6 (8)

0

2 (6)

NS

NS

NS

NA

GG

0

3 (1)

1 (1)

1 (1)

0

1 (3)

A*

202 (99)

419 (95)

167 (96)

146 (95)

38 (100)

58 (94)

p = 0.02; 5.06 [1.17–21.81]

NS

NS

NA

G

2 (1)

21 (5)

7 (4)

8 (5)

0

4 (6)

rs17047661A/G

AA

95 (93)

183 (83)

76 (87)

61 (79)

16 (84)

27 (87)

    

AG

7 (7)

31 (14)

9 (10)

13 (17)

3 (16)

3 (10)

p = 0.015; 3.05 [1.25–7.49]1

NS

p = 0.023; 3.74 [1.19–11.72]1

NS

GG

0

6 (3)

2 (2)

3 (4)

0

1 (3)

A*

197 (97)

397 (90)

161 (93)

135 (88)

35 (92)

57 (92)

p = 0.0042; 3.03 [1.34–9.9]

NS

p = 0.0017; 3.96 [1.62–9.68]

NS

G

7 (2)

43 (10)

13 (7)

19 (12)

3 (8)

5 (8)

rs4844609T/A

TT

100 (98)

213 (97)

84 (97)

75 (97)

18 (95)

30 (97)

    

TA

2 (2)

4 (2)

3 (3)

1 (1.5)

0

0

NS

NS

NS

NS

AA

0

3 (1)

0

1 (1.5)

1 (5)

1 (3)

T*

202 (99)

430 (98)

171 (98)

151 (98)

36 (95)

60 (97)

NS

NS

NS

NS

A

2 (1)

10 (2)

3 (2)

3 (2)

2 (5)

2 (3)

rs6691117A/G

AA

62 (61)

99 (45)

36 (41)

39 (51)

7 (37)

16 (52)

    

AG

33 (32)

99 (45)

43 (49)

31 (40)

8 (42)

12 (39)

p = 0.004; 2.22 [1.26–3.53]1

p = 0.006; 2.34 [1.28–4.27]1

NS

NS

GG

7 (7)

22 (10)

8 (9)

7 (9)

4 (21)

3 (10)

A*

157 (77)

297 (68)

115 (66)

109 (71)

22 (58)

44 (71)

p = 0.015;1.60 [1.09–2.35]

p = 0.02; 1.71 [1.09–2.69]

NS

p = 0.025; 2.42 [1.18–5.0]

G

47 (23)

143 (32)

59 (34)

45 (29)

16 (42)

18 (29)

  1. NA: Not applicable, NS: Not significant, *Major allele in the investigated population.